Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Cristian Pattaro is active.

Publication


Featured researches published by Cristian Pattaro.


Allergy | 2004

The role of climate on the geographic variability of asthma, allergic rhinitis and respiratory symptoms: results from the Italian study of asthma in young adults

Maria Elisabetta Zanolin; Cristian Pattaro; Angelo Corsico; Massimiliano Bugiani; Laura Carrozzi; Lucio Casali; Rossano Dallari; Marcello Ferrari; Alessandra Marinoni; E. Migliore; Mario Olivieri; Pietro Pirina; G. Verlato; Simona Villani; R. de Marco

Background:  Variations in the prevalence of respiratory symptoms according to geo‐climatic factors could provide important clues to the knowledge of the aetiology of asthma.


Allergy | 2006

Association between interleukin-1 receptor antagonist gene and asthma-related traits in a German adult population

Cristian Pattaro; Joachim Heinrich; M. Werner; R. de Marco; Matthias Wjst

Background:  A recent study in German and Italian families associated variants in the interleukin‐1 receptor antagonist (IL1RA) gene with asthma. The aim of the present study was to further investigate the role of single nucleotide polymorphisms (SNPs) in the IL1RA gene in the development of atopy and lifelong asthma in a population‐based study.


Psychiatry Research-neuroimaging | 2012

High dose benzodiazepine dependence: Description of 29 patients treated with flumazenil infusion and stabilised with clonazepam

Gianluca Quaglio; Cristian Pattaro; Gilberto Gerra; Sophie Mathewson; Paul Verbanck; Don C. Des Jarlais; Fabio Lugoboni

The withdrawal syndrome from benzodiazepine (BZD) can be severe and in some cases may impede cessation of the use of the drug. We present here a case series of benzodiazepine detoxification by flumazenil infusion, stabilised with clonazepam. Patients were treated with flumazenil 1.35 mg/day for a median of 7 days. Self-reported physical withdrawal symptoms were recorded daily. In addition to flumazenil, antidepressants were given before treatment commenced and clonazepam was administered nightly with both being continued after discharge. Twenty-nine patients were treated. No patients dropped out from the treatment programme. Nine patients (31%) required a temporary reduction/cessation of the infusion. The linear trend in the reduction of the daily withdrawal scores in the overall study population was significant. The linear trends were also significant in the group of patients for whom a temporary reduction/suspension of the flumazenil was required. Six months after treatment, 15 patients (53%) were abstinent from clonazepam and other BZDs. For five (21%) the BZD dependence were reinstated. More than two-thirds of the subjects tolerated the procedure well and about half had a good long term response. Slow flumazenil infusion appears to merit consideration as a possible future treatment. Suggestions for future research are examined.


BMC Public Health | 2006

Patients in long-term maintenance therapy for drug use in Italy: analysis of some parameters of social integration and serological status for infectious diseases in a cohort of 1091 patients

Gianluca Quaglio; Fabio Lugoboni; Cristian Pattaro; Linda Montanari; Alessandro Lechi; Paolo Mezzelani; Don C. Des Jarlais

BackgroundHeroin addiction often severely disrupts normal social functioning. The aims of this multi-centre study of heroin users in long-term replacement treatment were: i) to provide information on aspects of social condition such as employment, educational background, living status, partner status and any history of drug addiction for partners, comparing these data with that of the general population; ii) to assess the prevalence of hepatitis, syphilis and HIV, because serological status could be a reflection of the social conditions of patients undergoing replacement treatment for drug addiction; iii) to analyse possible relationships between social conditions and serological status.MethodsA cross-sectional study was carried out in sixteen National Health Service Drug Addiction Units in northern Italy. The data were collected from February 1, 2002 to August 31, 2002. Recruitment eligibility was: maintenance treatment with methadone or buprenorphine, treatment for the previous six months, and at least 18 years of age. In the centres involved in the study no specific criteria or regulations were established concerning the duration of replacement therapy. Participants underwent a face-to-face interview.ResultsThe conditions of 1091 drug treatment patients were evaluated. The mean duration of drug use was 14.5 years. Duration was shorter in females, in subjects with a higher educational background, and in stable relationships. Most (68%) had completed middle school (11–14 years of age). Seventy-nine percent were employed and 16% were unemployed. Fifty percent lived with their parents, 34% with a partner and 14% alone. Males lived more frequently with their parents (55%), and females more frequently with a partner (60%). Sixty-seven percent of male patients with a stable relationship had a partner who had never used heroin. HCV prevalence was 72%, HBV antibodies were detected in 42% of patients, while 30% had been vaccinated; 12.5% of subjects were HIV positive and 1.5% were positive for TPHA.ConclusionA significant percentage of heroin users in treatment for opiate addiction in the cohort study have characteristics which indicate reasonable integration within broader society. We posit that the combination of effective treatment and a setting of economic prosperity may enhance the social integration of patients with a history of heroin use.


Journal of Medical Virology | 2008

Prevalence and risk factors for viral hepatitis in the Kosovarian population: implications for health policy

Gianluca Quaglio; Naser Ramadani; Cristian Pattaro; Arben Cami; Pietro Dentico; Anna Volpe; Giampiero Pellizzer; Ali Berisha; Camillo Smacchia; Mario Figliomeni; Nicola Schinaia; Giovanni Rezza; Giovanni Putoto

The prevalence of hepatitis infection among the Kosovarian population is largely unknown. The aim of the study was to evaluate the prevalence and risk factors of hepatitis A, B, C, and D (HAV, HBV, HCV, HDV) infection among the general population and in a group of health care workers in the Kosovo region. Overall, 1,287 participants were recruited, 460 males (36%) and 827 females (64%). Health care workers accounted for 253 individuals (20%), 301 were blood donor candidates (23%), 334 were pregnant women (26%), and 399 (31%) were subjects who had been examined in two clinics for routine laboratory testing. The prevalence of total anti‐HAV was 88.6% (95% CI: 86.69–90.25). Prevalence of anti‐HAV among children up to 10 years was 40.5% (95% CI: 29.6–53.15), reaching 70% (95% CI: 62.25–77.10) in the 11–20 age group. Age, living in rural areas and unemployment were factors associated with higher risk of HAV infection. HBsAg was detected in 2.4% (95% CI: 1.57–3.38%) of the study sample, with a significant age trend (P‐value:0.0110). Positivity for total anti‐HBc was detected in 18.4% (95% CI = 16.27–20.59) of the subjects. Ninety‐three subjects (7.2%) were positive for anti‐HBs alone. An association between age, HSV‐2 positivity, working nurses and HBV infection has been observed. One patient was HDV positive. The prevalence for HCV was 0.5% (95% CI: 0.22–1.12%). HAV infection seems to be high‐intermediate, while HBV shows an intermediate endemicity. It is necessary to highlight the importance of an immunization strategy against HAV and HBV in reducing the incidence of the infection. The prevalence for HCV was very low. J. Med. Virol. 80:833–840, 2008.


American Journal on Addictions | 2010

Buprenorphine in maintenance treatment: experience among Italian physicians in drug addiction centers.

Gianluca Quaglio; Cristian Pattaro; Gilberto Gerra; Paolo Mezzelani; Linda Montanari; Don C. Des Jarlais; Fabio Lugoboni

The aim of this study was to assess the attitudes of Italian physicians regarding buprenorphine and its clinical use approximately 6 years after the medication was introduced into clinical practice. The sample consisted of 305 randomly selected physicians, working in public centers of drug addiction. In Italy buprenorphine seems a valid tool in the field of drug addiction treatment, although it is far from replacing methadone even though it seems to guarantee better compliance. Interviewees follow clinical experience more than international guidelines, with pharmaceutical company representatives as the most cited source for information about the medication. The data also suggests a need for the development of formal guidelines for treatment with buprenorphine in Italy.


The Journal of Allergy and Clinical Immunology | 2004

Influence of early life exposures on incidence and remission of asthma throughout life

Roberto de Marco; Cristian Pattaro; Francesca Locatelli; Cecilie Svanes


Drug and Alcohol Dependence | 2008

Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment

Gianluca Quaglio; Fabio Lugoboni; Cristian Pattaro; Barbara Melara; Paolo Mezzelani; Don C. Des Jarlais


Journal of Clinical Epidemiology | 2007

Using the age at onset may increase the reliability of longitudinal asthma assessment

Cristian Pattaro; Francesca Locatelli; Jordi Sunyer; Roberto de Marco


Journal of The American Academy of Dermatology | 2006

Classic Kaposi sarcoma in northern Sardinia : A prospective epidemiologic overview (1977-2003) correlated with malaria prevalence (1934)

Francesca Cottoni; Maria Vittoria Masala; Cristian Pattaro; Caterina Pirodda; Maria Antonia Montesu; Rosanna Satta; D. Cerimele; Roberto de Marco

Collaboration


Dive into the Cristian Pattaro's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Don C. Des Jarlais

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Giovanni Rezza

Istituto Superiore di Sanità

View shared research outputs
Researchain Logo
Decentralizing Knowledge